Matrix metalloproteinase 7 in diagnosis and differentiation of pulmonary arterial hypertension
Pulmonary arterial hypertension is a severe disease for which diagnosis often is delayed. Matrix metalloproteinases have been suggested to play a role in vascular remodeling and pulmonary hypertension development. Our aim was therefore to investigate the potential role of matrix metalloproteinases a...
Main Authors: | Mattias Arvidsson, Abdulla Ahmed, Habib Bouzina, Göran Rådegran |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2019-12-01
|
Series: | Pulmonary Circulation |
Online Access: | https://doi.org/10.1177/2045894019895414 |
Similar Items
-
Plasma proteoglycan prolargin in diagnosis and differentiation of pulmonary arterial hypertension
by: Mattias Arvidsson, et al.
Published: (2021-04-01) -
Prolargin and matrix metalloproteinase‐2 in heart failure after heart transplantation and their association with haemodynamics
by: Abdulla Ahmed, et al.
Published: (2020-02-01) -
Plasma receptor tyrosine kinase RET in pulmonary arterial hypertension diagnosis and differentiation
by: Joanna Säleby, et al.
Published: (2019-11-01) -
Plasma adrenomedullin peptides and precursor levels in pulmonary arterial hypertension disease severity and risk stratification
by: Habib Bouzina, et al.
Published: (2020-06-01) -
Low plasma stem cell factor combined with high transforming growth factor-α identifies high-risk patients in pulmonary arterial hypertension
by: Habib Bouzina, et al.
Published: (2018-11-01)